Cell adhesion receptor expression during melanoma progression and metastasis.
about
Hyaluronan and the hyaluronan receptor RHAMM promote focal adhesion turnover and transient tyrosine kinase activityProliferation behavior of E. coli in a three-dimensional in vitro tumor model.Expression of CD44 in human neoplastic and normal hyaline cartilage.Alternatively spliced variants of the cell adhesion molecule CD44 and tumour progression in colorectal cancer.Osteopontin is an endogenous modulator of the constitutively activated phenotype of pulmonary adventitial fibroblasts in hypoxic pulmonary hypertension.Inhibition of tumor growth in vivo with a soluble CD44-immunoglobulin fusion protein.Residues within a conserved amino acid motif of domains 1 and 4 of VCAM-1 are required for binding to VLA-4N-methylformamide induces changes on adhesive properties and lung-colonizing potential of M14 melanoma cells.Interaction between CD44 and hyaluronate is directly implicated in the regulation of tumor development.CD44H regulates tumor cell migration on hyaluronate-coated substratesiRNA-mediated silencing of integrin β3 expression inhibits the metastatic potential of B16 melanoma cells.Focus on TILs: Prognostic significance of tumor infiltrating lymphocytes in human bladder cancer.Mediation of NGF-stimulated extracellular matrix invasion by the human melanoma low-affinity p75 neurotrophin receptor: melanoma p75 functions independently of trkA.Evaluation of (68)Ga- and (177)Lu-DOTA-PEG4-LLP2A for VLA-4-Targeted PET Imaging and Treatment of Metastatic Melanoma.Contribution of very late antigen-4 (VLA-4) integrin to cancer progression and metastasis.Matched rabbit monoclonal antibodies against αv-series integrins reveal a novel αvβ3-LIBS epitope, and permit routine staining of archival paraffin samples of human tumors.Ultraviolet A exposure alters adhesive properties of mouse melanoma cells.Suppression of CD44 expression decreases migration and invasion of human glioma cells.The biochemistry of cancer dissemination.Homotypic leukocyte aggregation triggered by a monoclonal antibody specific for a novel epitope expressed by the integrin beta 1 subunit: conversion of nonresponsive cells by transfecting human integrin alpha 4 subunit cDNA.Uveal melanoma: tumour phenotype and metastatic potential.Variant expression of CD44 in preneoplastic lesions of the lung.Expression of fibronectin, fibronectin isoforms and integrin receptors in melanocytic lesions.PET imaging of very late antigen-4 in melanoma: comparison of 68Ga- and 64Cu-labeled NODAGA and CB-TE1A1P-LLP2A conjugates.Influence of MUC18/MCAM/CD146 expression on human melanoma growth and metastasis in SCID mice.CD44 and melanocytic tumors: a possible role for standard CD44 in the epidermotropic spread of melanoma.Expression of integrin subunits and CD44 isoforms in psoriatic skin and effects of topical calcitriol applicationCD44v3 levels in primary cutaneous melanoma are predictive of prognosis: Assessment by the use of tissue microarray
P2860
Q24651389-965D5280-43FB-497E-B7B7-4CF02717B4B3Q35708412-45D8D490-9DEC-4F16-A912-D5DDB56B0348Q35836306-C1307BE8-AF00-42D5-BA12-FDB4F6AB967AQ36135737-215E10BE-8F6E-4453-9715-683D369B6906Q36185483-DCA69F3E-6CD5-4B54-9F4C-2B0BC4EAAFDFQ36231630-A14F70C5-6843-4C82-911A-A8D8B24AFF73Q36234074-8FD3C316-0DCF-4009-897E-AF7D6C3C930FQ36294927-5D6A5C68-4EA0-47BE-B767-DDDC19AEBB22Q36363467-3CCEFB1B-0A60-4B4B-86F8-4444E3310D97Q36531720-D4AFC5EA-A15D-4D70-AE17-0BAFB7232E34Q36642289-F794C4E6-5443-45BF-A353-FB771C638A6DQ36860110-C3A45914-8DB1-49A1-94A8-BC58545190C1Q37376563-CA441B3D-34C6-4FBA-B240-A8977438B75AQ37515861-775CE159-57A9-4EF6-9BFF-7918CD61F231Q38309552-F6DA15B6-57F6-4F2C-B942-5365132520B6Q38399145-7700665B-7D37-4AB6-BF84-4F87D22E5892Q40376056-7235B3AA-F142-4C9D-9EA4-F07A2896D999Q41206375-D1D9AD24-F93B-4F3D-A2F0-DE845B2B8E73Q41547351-48F804B9-354F-428B-9F55-A08B55D892C1Q41564510-C64AFE15-A341-489C-9960-BF414FA1CE63Q41625942-F1DB6F68-11A4-46ED-9757-206A786C1025Q42510592-4BDF0569-4595-483F-9981-DB5DE908B92DQ42590655-46A18B2B-D76F-4288-ACC3-9DF9A38B841BQ43082545-0D7EAC9F-FE5D-48BD-93E0-912B0B34168DQ48189982-BA5ACC0A-EBA3-46FC-9E29-3B0A52504CA7Q50750644-A6451EFA-CB07-4EFA-98F7-EA24C836F0FCQ56087794-D943520D-DF71-4878-9719-35D278FAF615Q57351327-76983489-EDF9-49B4-B994-5ED8A258CFDF
P2860
Cell adhesion receptor expression during melanoma progression and metastasis.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on June 1991
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Cell adhesion receptor expression during melanoma progression and metastasis.
@en
Cell adhesion receptor expression during melanoma progression and metastasis.
@nl
type
label
Cell adhesion receptor expression during melanoma progression and metastasis.
@en
Cell adhesion receptor expression during melanoma progression and metastasis.
@nl
prefLabel
Cell adhesion receptor expression during melanoma progression and metastasis.
@en
Cell adhesion receptor expression during melanoma progression and metastasis.
@nl
P2093
P356
P1476
Cell adhesion receptor expression during melanoma progression and metastasis.
@en
P2093
P2860
P2888
P304
P356
10.1007/BF00049409
P577
1991-06-01T00:00:00Z